Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)-butoxy]-1H-quinolin-2-one

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 10,732Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rxulti® approved in EU for treating schizophrenia in adolescents
    Rxulti® approved in EU for treating schizophrenia in adolescents

    13 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rxulti-brexpiprazole-approved-in-the-european-union-for-the-treatment-of-schizophrenia-in-adolescents-aged-13-years-and-older-302400911.html

    PR NEWSWIRE
    13 Mar 2025
    Share Share
    Alembic Pharma Gets USFDA Approval For Brexpiprazole Tablets
    Alembic Pharma Gets USFDA Approval For Brexpiprazole Tablets

    15 Jan 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/alembic-pharma-gets-usfda-final-approval-for-brexpiprazole-tablets-0-25-mg-0-5-mg-1-mg-2-mg-3-mg-and-4-mg/

    EXPRESSPHARMA
    15 Jan 2025
    Share Share
    Prinston`s Generics Brexpiprazole Receives Tentative Approval in US
    Prinston`s Generics Brexpiprazole Receives Tentative Approval in US

    21 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213587

    FDA
    21 Oct 2024
    Share Share
    Otsuka And Lundbeck Present REXULTI® Data At AAIC 2024
    Otsuka And Lundbeck Present REXULTI® Data At AAIC 2024

    31 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240731398299/en

    BUSINESSWIRE
    31 Jul 2024
    Share Share
    Otsuka Announce FDA Acceptance of sNDA for Brexpiprazole and Sertraline
    Otsuka Announce FDA Acceptance of sNDA for Brexpiprazole and Sertraline

    25 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240625407910/en

    BUSINESSWIRE
    25 Jun 2024
    Share Share
    Otsuka, Lundbeck: Brexpiprazole Plus Sertraline Data In PTSD Presented
    Otsuka, Lundbeck: Brexpiprazole Plus Sertraline Data In PTSD Presented

    28 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240528141173/en

    BUSINESSWIRE
    28 May 2024
    Share Share